FDA Strengthens Warnings on Sleeping Pills

Labels must list side effects such as sleep-driving and allergic reactions

By Steven Reinberg
HealthDay Reporter

Related Encyclopedia • Acidophilus • Antioxidants • Caffeine (and its effects) • Calcinosis More... Related Healthscout Videos Help for Restless Legs Sleep Science Insomnia Power Out Fat More... Related Drug Information • Klor-Con • Klor-Con ER More... Related News Articles • Physicians Say They Need More Sleep • Government Assistance Linked to Better Child Development • Bacteria Mix in Guts of Babies Predicts Obesity • Heparin Problems Reported in Germany More...

WEDNESDAY, March 14 (HealthDay News) -- Prescription sleeping pills, including such popular brands as Ambien and Lunesta, can cause strange and potentially dangerous side effects, the U.S. Food and Drug Administration warned Wednesday.

Those side effects can include dangerous allergic reactions and bizarre behaviors such as "sleep-driving," in which a person will drive a car while not fully awake and have no memory of doing so.

Text Continues Below

---

The FDA is asking makers of the sleep aids, called sedative-hypnotic drugs, to strengthen product labels to include stronger warnings about the potential risks. In addition to "sleep-driving," the agency said it has received reports of consumers walking or eating while not fully awake, and not remembering it later.

"Because these drugs are designed to put people to sleep, they might not know that they are having a side effect," Dr. Russell Katz, director of the FDA's Division of Neurology in the Office of Drug Evaluation I, Center for Drug Evaluation and Research, said during a teleconference.

Sleep-driving and other strange behaviors might occur if consumers take a higher-than-recommended dose of the drug, or drink alcohol or consume other similar drugs, Katz said. "We believe that all the drugs in the class can produce these effects," he said.

Katz said it's not possible to know how many cases of these side effects have occurred because the system for reporting adverse effects is voluntary. "We believe these are rare occurrences," he said. "But we don't know the actual number of cases."

The 13 drugs involved are: Ambien and Ambien CR, made by Sanofi Aventis; Butisol Sodium, made by Medpointe Pharm HLC; Carbrital, made by Parke-Davis; Dalmane made by Valeant Pharm; Doral made by Questcor Pharms; Halcion, made by Pharmacia & Upjohn; Lunesta, made by Sepracor; Placidyl and Prosom, made by Abbott; Restoril, made by Tyco Healthcare; Rozerem, made by Takeda; Seconal, made by Lilly; and Sonata, made by King Pharmaceuticals.

Page:  1 | 2 | 3 | Next >>